Dame Jane Osbourn, chief scientific officer at Alchemab Therapeutics, speaks with Ahuva Nissim, antibody and therapeutic engineering professor at Queen Mary University of London William Harvey Research Institute, about the career path that took her from studying molecular biology and building human phage libraries to developing therapeutics with convergent protective antibodies. Osbourn talks about the most inspiring mentors of her career, her interest in immunological resiliency, the importance of studying neurodegenerative diseases, and her drug discovery work at Alchemab Therapeutics. Finally, she talks about the technological advancements she hopes will move precision medicine forward in the near and distant future.
The Chain: Protein Engineering Podcast